Search

Kidney Program

Page

HSCI researchers are dedicated to finding new treatments for patients with kidney disease.

Kidney injury molecule linked to chronic kidney disease

News

More than 15 years after the discovery of kidney injury molecule-1 (KIM-1) by Joseph Bonventre, MD, PhD, researchers in the HSCI Kidney Disease Program—of which Bonventre is a member—have found that the molecule promotes the scar tissue formation...

Mechanisms and treatment of kidney glomerular disease

Events

HSCI Kidney Program Inter-lab Meeting Open to all members of the HSCI research community - no registration required. Guest speakers: Anna Greka, MD, PhD Assistant Professor of Medicine, Harvard Medical School Institute Member, Broad Institute of MIT and...

Disease Programs

Page

Through disease-specific programs, HSCI channels its world-class resources — both intellectual and technological — toward some of the most prevalent, devastating diseases for which stem cell research can hold promise. Blood Program Led by Daniel G. Tenen...

HSCI Disease Program Seminar Series

Events

Register by clicking here. Presenter: Marc Wein, MD, PhD | Massachusetts General Hospital Molecular determinants of renal vitamin D metabolism in mice and human kidney organoids Moderator: M. Todd Valerius, PhD | HSCI Kidney Disease Program Leader

2012 HSCI call for proposals – Kidney Program pilot grants

News

The Harvard Stem Cell Institute (HSCI) Kidney Program invites applications for up to two Program Grant and up to two Pilot Grants for 2012. The purpose of this funding program is to provide resources for research in adult kidney disease with the goal of...

HSCI Disease Program Seminar Series

Events

Register by clicking here. Presenter: Ryuji Morizane, MD, PhD | Massachusetts General Hospital | Harvard Medical School Maturing Kidney Organoids for Disease Modeling and Regenerative Medicine Moderator: M. Todd Valerius, PhD | HSCI Kidney Disease Program...

Patient stem cells offer insight into origins of polycystic kidney disease

News

Harvard Stem Cell Institute (HSCI) scientists have identified a new therapeutic approach for treating polycystic kidney disease (PKD), one of the most common life threatening, inherited diseases in humans, affecting more than 1 in 500 individuals...

‘Phase two’ ushers in new leadership and direction in disease programs

Page

HSCI’s mission is to find cures or treatments for diseases that cause disability and death for millions—scourges like cancer, diabetes, and cardiovascular disease. To help achieve this goal, a large body of HSCI research is organized within disease...

2013 HSCI call for proposals – Kidney Program pilot grants

News

SUBMISSION DEADLINE: Thursday, November 15, 2012 - 5:00 p.m. EST The Harvard Stem Cell Institute (HSCI) Kidney Program invites applications for Pilot Grant funding for 2013. The purpose of this funding program is to provide resources for research in adult...

Adult kidney stem cells found in fish

News

It has long been a given that adult humans — and mammals in general — lack the capacity to grow new nephrons, the kidney’s delicate blood filtering tubules, which has meant that dialysis, and ultimately kidney transplantation, is the only option for the...

HSCI pilot grants foster innovation and collaboration

Page

To stimulate innovation and collaboration and further expand the community of scientists engaged in stem cell research, several of HSCI’s disease programs initiated pilot grants last year. Ranging from $36,000 to $100,000 a year, these grants provide...